Late Infantile Metachromatic Leucodystrophy Effect of Low Vitamin A Diet
Late infantile metachromatic leucodystrophy (MLD) is a genetically determined, generalized, sulphatide lipidosis, in which lipid metachromatic substances accumulate in the nervous system and other organs, due to a deficiency of the lysosomal enzyme, arylsulphatase A (Austin et al., 1964; Mehl and Jatzkewitz, 1965) .
The disease is characterized by a slowly progressive course which has been divided into four stages according to the degree of motor handicap (Hagberg, 1963) . The first symptoms and signs generally appear between 1 and 2 years in a previously normal child, and consist of hypotonia, unsteady gait, and valgus deformity of feet. The child gradually loses the ability to walk, sit, or crawl, and develops spasticity, with diminished or absent tendon reflexes, and may in addition show ataxia and tremor (stages I and II). Mental regression, hypertonic spasms, violent root pains, and total aphasia follow (stage III), and the child eventually dies between 3 and 6 years in a state of decerebrate rigidity, with cortical blindness and deafness (stage IV).
Attempts to alter the course of this disease by various therapeutic means have so far not met with any success. Because vitamin A is necessary for one of the metabolic steps in the synthesis of sulphatide (Sundaresan, 1966) , Melchior and Clausen (1968) tried a vitamin A deficient diet in the treatment of a child with advanced MLD, but did not obtain any clinical improvement. We report a further case of MLD in which we tried a vitamin A deficient diet, with some apparent success.
Case Report A girl presented at the age of 21 years with delay in walking. She was born normally at 37 weeks' gestation weighing 2920 g. The neonatal period was normal. In the first year she reached her developmental milestones quite normally-she sat unsupported at 6 to 7 months and pulled herself to a standing position at 9 to 10 months but did not achieve the ability to walk independently, and at the age of 2 years 3 months, she could just take two to three steps unsupported. Her intellectual development seemed quite normal. She could talk well, making sentences of 4 to 5 words.
On examination at that stage, the only abnormal findings were slight hypotonia, especially in relation to the knee joint which would go into recurvatum when weight was taken on them; absent knee and ankle jerks; and a convergent concomitant squint. The fundi were normal. Her intelligence was difficult to assess because of poor co-operation. Delayed motor development with possible laxity of ligaments around the knee joints was diagnosed and she was given a course of physiotherapy.
Three months later there was no obvious change but she was reluctant to walk unless supported. The hypotonia was more pronounced. The knee jerks were still absent. Ankle jerks and the plantar response were equivocal. She was irritable and readily distressed when examined.
Four months later she was described by her parents as being 'ever so nervous', trembling all the time, would not sit or stand, was uncooperative, and 'not bothering to do anything'. This the parents attributed to the arrival of the new sib. On examination, she was unable to maintain a sitting or standing position without support. It was noted that intermittently her right knee would hyperextend and the whole leg would go stiff.
Because of definite weakness in her limbs at that stage, it was decided to do a muscle biopsy to exclude an underlying neuromuscular disorder.
On routine histological stain the quadriceps muscle showed no striking abnormality. There was an obvious variation in fibre size, falling into two populations, one about 30,u in diameter and the other about 60,u. Course and therapy. After confirnation of the diagnosis, she was given a diet low in vitamin A (approximately 500-900 IU/day), with supplementary vitamins C and D.
When reassessed 6 weeks later there was an undoubted improvement. She had become more responsive, and attempted to smile and to speak when spoken to. She was able to chew and swallow without difficulty. Her hands were more relaxed and she opened them more frequently. When examined, she was more alert, was cheerful and did not become distressed when touched. The nystagmus was no longer present, and though her legs were still hypertonic and extended, it was easier to overcome the resistance than before. The reflexes were still absent.
She has now been followed up for over 2 years since starting the low vitamin A therapy. After the initial improvement her condition remained fairly static. She is still unable to sit or stand and has complete aphasia. She is unable to swallow solids but manages semisolids quite well. She is responsive and alert and tums to her father when spoken to. Extensor spasms, especially of her leg, still occur occasionally and the reflexes are all absent. Her nerve conduction velocities remain very slow (Table II) . dramatic improvement in the clinical state and the motor nerve conduction velocity would not be surprising. It is unlikely that any damage already caused by the excessive sulphatide would be corrected and the most one could hope for with the low vitamin A therapy would be to reduce any further accumulation of sulphatide and thereby limit the progression of the disease.
Early diagnosis is therefore all important. Peripheral motor nerve conduction velocity measurement (Fullerton, 1964; Aziz and Pearce, 1968) could be useful in this regard as a screening test, especially in the early stage when the only abnormal signs may be a slight hypotonia, or a genu valgum deformity with depressed or absent tendon reflexes. The diagnosis should thus be suspected in any previously normal child developing hypotonia or delay in motor milestones in the 2nd year of life. If a slow motor nerve conduction velocity is found the diagnosis can then be confirmed by demonstrating low levels of arylsulphatase activity in the blood or urine (Percy and Brady, 1968; Austin, McAfee, and Shearer, 1965) . In our family we have also been able to show some reduction in levels of arylsulphatase A in the blood and the urine in the parents as well as the younger sib. It is thus possible also to identify heterozygotes for the recessive gene.
While it is difficult to assess the value of any form of therapy in a slowly progressive condition on the basis of a single case, we have been sufficiently impressed by the change in this patient to draw attention to its possible value, and at the same time to stress the importance of early recognition of this condition for future therapeutic trials. Summary A 3-year-old girl with metachromatic leucodystrophy showed an apparent improvement when put on a diet low in vitamin A. During a 2-year follow-up she subsequently showed no progression of the disease. The importance of early diagnosis by nerve conduction velocity studies and measurement of arylsulphatase levels in the leucocytes or urine is stressed in order to try and arrest the disease at an early stage. Heterozygotes can also be identified by lowered arylsulphatase levels in leucocytes and urine. 
